How tiny worms help scientists learn how bodies sense gravity
Identifying molecular mechanisms of responding to gravity using the nematode C. elegans
Scientists are using microscopic roundworms to find the molecules and nerve cells that let living things sense gravity, which could help people with balance problems like those caused by Parkinson’s disease or aging.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11169992 on NIH RePORTER |
What this research studies
If you have balance problems, this work aims to uncover basic molecules and nerve cells that help sense gravity. The team studies tiny roundworms (C. elegans) because their simple nervous system is easy to change and observe. They will turn off or control specific dopamine-producing neurons (CEP, ADE, PDE) with genetic and light-activated tools to see which are needed for gravity responses. They will also search for other chemical messengers that help the worms move with respect to gravity.
Who could benefit from this research
Good fit: People with Parkinson’s disease or older adults who have trouble with balance and falls would be the most relevant groups for future clinical follow-up of this work.
Not a fit: People whose balance problems are caused mainly by inner-ear mechanical issues, orthopedic problems, or cardiovascular causes may not benefit directly from this worm-based molecular research.
Why it matters
Potential benefit: If successful, this could point to new targets for treatments to improve balance and reduce falls in people with Parkinson’s disease and older adults.
How similar studies have performed: Using C. elegans and genetic/optogenetic tools to map neural circuits is an established approach, but applying these methods specifically to gravity sensing and its link to Parkinson’s-related falls is a newer direction.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Raizen, David Menassah — University of Pennsylvania
- Study coordinator: Raizen, David Menassah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.